N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability

L Zou, W Chen, X Zhou, T Yang, J Luo, Z Long… - Cell Death …, 2022 - nature.com
The fat mass and obesity-associated protein (FTO) is an N6-Methyladenosine (m6A)
demethylase, which has been revealed to play critical roles in tumorigenesis. However, its …

The Macrophage-Associated LncRNA MALR Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer

J Liu, ZX Liu, JJ Li, ZL Zeng, JH Wang, XJ Luo… - Cancer Research, 2023 - AACR
Tumor-associated macrophages (TAM) are among the most abundant immune cells in the
tumor microenvironment and are important mediators of tumor development and …

[HTML][HTML] Regulatory mechanisms and therapeutic implications of insulin-like growth factor 2 mRNA-binding proteins, the emerging crucial m6A regulators of tumors

H Zhou, Q Sun, M Feng, Z Gao, S Jia, L Cao, X Yu… - Theranostics, 2023 - ncbi.nlm.nih.gov
Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) serve essential biological
functions as post-transcriptional performers, participating in the acquisition or maintenance …

[HTML][HTML] M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for …

C Zhong, Z Long, T Yang, S Wang… - … Journal of Biological …, 2023 - ncbi.nlm.nih.gov
Abstract N6-Methyladenosine (m6A) is the most prevalent RNA modification in various types
of RNA, including circular RNAs (circRNAs). Mounting evidence has shown that circRNAs …

[HTML][HTML] ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner

P Li, Y Shi, D Gao, H Xu, Y Zou, Z Wang… - International Journal of …, 2022 - ncbi.nlm.nih.gov
Background: N6-methyladenosine (m6A) is one of the most prevalent mRNA modifications
in mammals, and it regulates the fate of modified RNA transcripts. In the current study, we …

The functions and mechanisms of post-translational modification in protein regulators of RNA methylation: Current status and future perspectives

Y Chen, Z Jiang, Y Yang, C Zhang, H Liu… - International Journal of …, 2023 - Elsevier
RNA methylation, an epigenetic modification that does not alter gene sequence, may be
important to diverse biological processes. Protein regulators of RNA methylation include …

RNA m6A methylation in cancer

Z Wang, J Zhou, H Zhang, L Ge, J Li… - Molecular …, 2023 - Wiley Online Library
N 6‐methyladenosine (m6A) is one of the most abundant internal modifications in eukaryotic
messenger RNAs (mRNAs) and non‐coding RNAs (ncRNAs). It is a reversible and dynamic …

Crosstalk between m6A regulators and mRNA during cancer progression

X Niu, Y Yang, Y Ren, S Zhou, Q Mao, Y Wang - Oncogene, 2022 - nature.com
Abstract m6A modification, the most abundant and widespread RNA modification, is present
and involved in the occurrence and development of various cancers. To date, most studies …

FTO inhibits epithelial ovarian cancer progression by destabilising SNAI1 mRNA through IGF2BP2

M Sun, X Zhang, F Bi, D Wang, X Zhou, X Li, Q Yang - Cancers, 2022 - mdpi.com
Simple Summary Ovarian cancer is the gynaecologic malignant tumour with the highest
mortality. Most patients are already in the advanced stage when they are found, and the 5 …

[HTML][HTML] Novel insights into m6A modification of coding and non-coding RNAs in tumor biology: From molecular mechanisms to therapeutic significance

J Jia, S Wu, Z Jia, C Wang, C Ju, J Sheng… - … Journal of Biological …, 2022 - ncbi.nlm.nih.gov
Accumulating evidence has revealed that m 6 A modification, the predominant RNA
modification in eukaryotes, adds a novel layer of regulation to the gene expression. Dynamic …